Wave Life Sciences (WVE) Long-Term Deferred Tax (2014 - 2017)

Wave Life Sciences (WVE) has 4 years of Long-Term Deferred Tax data on file, last reported at $774000.0 in Q2 2017.

• Quarterly Long-Term Deferred Tax rose 303.12% year-over-year to $774000.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $774000.0 (up 303.12% YoY) and the FY2016 annual result came in at $560000.0, up 191.67% from the prior year.
• Long-Term Deferred Tax was little changed at $774000.0 in Q2 2017, from $774000.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $774000.0 in Q1 2017 to a low of $32000.0 in Q3 2016.
• A 4-year average of $362250.0 and a median of $192000.0 in 2015 frame the typical range for Long-Term Deferred Tax.
• Annual changes were most pronounced in 2015 — Long-Term Deferred Tax grew 5.49% — and 2017, when it surged 303.12%.
• Tracing WVE's Long-Term Deferred Tax over 4 years: stood at $182000.0 in 2014, then climbed by 5.49% to $192000.0 in 2015, then surged by 191.67% to $560000.0 in 2016, then surged by 38.21% to $774000.0 in 2017.
• The last three Long-Term Deferred Tax figures came in at $774000.0 (Q2 2017), $774000.0 (Q1 2017), and $560000.0 (Q4 2016), per Business Quant data.